ALS Recent Progress Evaluation at MDA 2023.

Published Date: 01 Mar 2023

In the MDA session track on amyotrophic lateral sclerosis, Stanley Appel, MD, provided his perspective on the condition, the most recent scientific developments that will benefit patients, and the direction that research and treatment in the area are taking.

Read Full News

Latest News

US FDA's Accelerated Approval for Drugs Needs More Transparency, Says Research Firm

The U.S. Food and Drug Administration should be more transparent when granting accelerated approval for certain drugs, influential drug pricing body, Institute for Clinical...

Common Genetic Cause of Intellectual Disability Identified

A newly identified recessive neurodevelopmental disorder may be among the most common genetic causes of intellectual disability and epilepsy, new research suggests.

Roche: New Elevidys Study After Feedback From EU Regulator

Roche said it is initiating a late stage study for its ⁠gene therapy Elevidys following feedback from the European drug regulator.

New Evidence Strengthens the Case for Iatrogenic Alzheimer’s

Researchers report the first autopsy-confirmed case of Alzheimer's disease following suspected medical transmission, but experts say definitive causation may remain elusive.

Experts Push Back on WHO’s ‘Misleading’ Portrayal of ECT

Leading psychiatry groups say WHO guidance on ECT risks stigmatizing and reducing access to a safe, effective, and sometimes life-saving treatment for patients with severe mental illness.

Do Early Birds Have a Lower Risk for ALS?

Earlier bedtime and wake time and regular physical activity are associated with a significant reduction in ALS risk, a new study shows.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Latest News

The U.S. Food and Drug Administration should be more transparent when granting accelerated approval for certain drugs, influential drug pricing body, Institute for Clinical...

A newly identified recessive neurodevelopmental disorder may be among the most common genetic causes of intellectual disability and epilepsy, new research suggests.

Roche said it is initiating a late stage study for its ⁠gene therapy Elevidys following feedback from the European drug regulator.

Researchers report the first autopsy-confirmed case of Alzheimer's disease following suspected medical transmission, but experts say definitive causation may remain elusive.

Leading psychiatry groups say WHO guidance on ECT risks stigmatizing and reducing access to a safe, effective, and sometimes life-saving treatment for patients with severe mental illness.

Earlier bedtime and wake time and regular physical activity are associated with a significant reduction in ALS risk, a new study shows.

News All Time

Late Complications Common After CVT, Even After Recovery

Although a majority of patients with cerebral venous sinus thrombosis achieve independence, 1 in 3 may develop delayed complications such as seizures, a study shows.

Activity Trackers May Predict MS Progression

Reduced daytime physical activity, as measured with wearable trackers, is tied to increased risk for multiple sclerosis progression and brain atrophy, new research shows.

WHO Warns Of Health Risks From 'Black Rain' in Iran

The World Health Organization warned on Tuesday that the 'black rain' and toxic compounds in the air in Iran after strikes on ⁠oil facilities could cause respiratory problems.

Wildfire Smoke Tied to Higher Stroke Risk, Greater Severity

Short-term surges in air pollution from wildfire smoke have been linked to a greater incidence and severity of stroke.

Therapeutic Research in Alzheimer’s Disease: What Is New?

Long-term extension trial results with donanemab suggest a widening separation in cognitive decline through 36 months in early Alzheimer’s disease.

Reframing Dyslexia: Ancient Genes, Modern Skill

Study argues to move beyond ‘reading genes’ — focus on conserved neural-development networks in humans to improve early screening and identify therapeutic leads.

Adults With IDDs Face ‘Mental Health Crisis’

Adults with IDDs face disproportionately higher rates of anxiety and depression and barriers to care, prompting researchers to characterize the situation as a ‘mental health crisis.’

Positive Topline Results for Efgartigimod in Ocular MG

Efgartigimod led to statistically significant improvement in key symptoms of ocular myasthenia gravis compared with placebo in a phase 3 trial.

Smoking + Parkinson's: Lower Disease Risk, Higher Mortality

A large nationwide study revisits the smoking-Parkinson's paradox, linking current smoking to lower disease risk but linking quitting to lower all-cause mortality.

Stem Cell Therapy Safe, Feasible in Spina Bifida

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal myelomeningocele repair.

Does Caring for Grandchildren Slow Cognitive Decline?

Grandmothers who care for grandchildren show slower cognitive decline over time than non-caregivers do.

Teen Cannabis Use Tied to Increase in Serious Mental Illness

A new study shows that teens with past-year cannabis use are twice as likely to be diagnosed with psychotic or bipolar disorders within 2 years of first use.

Fertility Treatments Linked to Higher Med Use in Offspring

Children conceived through medically assisted reproduction have higher out-of-hospital healthcare utilization including mental health medications.

Lifetime Risk Estimates for Dementia, MCI: New Data

Mild cognitive impairment before dementia is common in older adults, with women facing a higher lifetime burden and Black adults an earlier onset, new research shows.

Fibromyalgia-PTSD Link Shows Bidirectional Relationship

Research suggests a bidirectional relationship between posttraumatic stress disorder and fibromyalgia in military service members exposed to combat environments.

Redefining Cognitive Assessment With One Blood Test

Blood p-tau217 testing in real-world practice enhances diagnostic accuracy and neurologists' diagnostic confidence, with the greatest diagnostic shifts seen in mild cognitive impairment and dementia.

Recommended News For You

Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

Does pollution cause cancer?

Drug-chemo combo increases cancer treatment efficacy

New analysis helps discern benign from malignant thyroid growths

Recommended Articles For You

Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results 

Understanding the Rare Disease: Werner Syndrome Explained  

Unlocking the Power of Cryoprecipitate: A Comprehensive Guide 

Anemia in Older Adults: Causes, Clinical Impact, and Evidence-Based Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

2.

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

3.

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

4.

Lymph node transfer reduces arm swelling after breast cancer surgery, study shows

5.

Gene therapy for glioblastoma is effectively created by researchers.

1.

Uncovering the Secrets of CA19-9: A Blood Test for Cancer Diagnosis

2.

Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia

3.

Navigating the Complexities of Esophageal Cancer Staging

4.

Role of Type I Interferons and KDM1B in Driving Cancer Stemness and Therapeutic Evasion

5.

Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part III

2.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

3.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

4.

Navigating the Complexities of Ph Negative ALL - Part XI

5.

Navigating the Complexities of Ph Negative ALL - Part XV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot